Showing results (201-210 of 8,998) with videos related to

Sort By:
Pageof 900
European Journal of Clinical Pharmacology|July 30, 1978
Effect of active metabolites of chlordiazepoxide and diazepam, alone or in combination with alcohol, on psychomotor skills related to drivingE S Palva, M Linnoila
European Journal of Clinical Pharmacology|March 5, 2022
Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysisDimy Fluyau, Paroma Mitra, Ankit Jain, et al.
European Journal of Clinical Pharmacology|May 13, 2019
Medicine use and medicine-related problems in patients with liver cirrhosis: a systematic review of quantitative and qualitative studiesEjaz Cheema, Aliaa Al-Aryan, Abdullah Al-Hamid
European Journal of Clinical Pharmacology|March 15, 2022
Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records databaseMohamed Kadry Taher, James A G Crispo, Yannick Fortin, et al.
European Journal of Clinical Pharmacology|February 14, 2022
Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic reviewSimone Skullbacka, Marja Airaksinen, Juha Puustinen, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Treatment of persistent fetal circulation syndrome of the newborn. Comparison of different doses of tolazolineP Monin, C Dubruc, P Vert, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal functionJ Braun, J R Kollert, J U Becker
European Journal of Clinical Pharmacology|February 23, 1999
Statins and peripheral neuropathyU Jeppesen, D Gaist, T Smith, et al.
European Journal of Clinical Pharmacology|February 23, 1999
No clinically relevant effect of lornoxicam intake on acenocoumarol pharmacokinetics and pharmacodynamicsU P Masche, K M Rentsch, A von Felten, et al.
European Journal of Clinical Pharmacology|February 23, 1999
Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activitiesP Fuchs, W E Haefeli, H R Ledermann, et al.
Pageof 900